560 Immunotherapeutic and antimetastatic activity of LTX-315 in preclinical models of ICI-resistant breast cancer

• Xi Zhou,
• Sandra Demaria,
• Baldur Sveinbjörnsson,
• Öystein Rekdal,
• Erik Wennerberg,
• Lorenzo Galluzzi,
• Takahiro Yamazaki,
• Michal Hensler,
• Jitka Fucikova,
• Aitziber Buqué Martinez,
• Jeffrey Kraynak

Affiliations

Xi Zhou

Orthopaedic Surgery, Peking Union Medical College Hospital, Beijing, China

Sandra Demaria

Department of Radiation Oncology, Weill Cornell Medical College, New York, New York, USA

Baldur Sveinbjörnsson

Aff2 grid.10919.300000000122595234University of Tromsö Tromsö Norway

Öystein Rekdal

Aff1 Lytixbiopharma, Oslo, Norway Oslo Norway

Erik Wennerberg

9Weill Cornell Medicine, New York, NY, USA

Lorenzo Galluzzi

Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA

Takahiro Yamazaki

Aff2 grid.14925.3b0000000122849388Gustave Roussy Cancer Campus Villejuif France

Michal Hensler

Aff2 grid.476702.0Sotio Prague Czech Republic

Jitka Fucikova

Sotio Biotech, Prague, Czech Republic

Aitziber Buqué Martinez

Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA

Jeffrey Kraynak

1Weill Cornell Medical College, New York, NY, USA